News 
Market Data 
Discover
Replies to post #7783 on Mind Medicine (MindMed) Inc (MNMD)
The Utah House of Representatives on Thursday overwhelmingly approved a bill to create a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations for their lawful use.
The chamber approved the legislation from Rep. Brady Brammer (R), which cleared the House Health and Human Services Committee last week, in a 68-1 vote.
“We need effective tools to treat mental illness,” Brammer said on the floor ahead of the vote, “and if psychedelics can be helpful and safely administered, we need them in our toolbox.”
The psychedelics bill would create a Mental Illness Psychotherapy Drug Task Force, which would be required to “study and make recommendations on drugs that may assist in treating mental illness.” The psychotherapy drugs that the panel would consider are defined as controlled substances that are “not currently available for legal use” and “may be able to treat, manage, or alleviate symptoms from mental illness.”
Brammer has previously recognized that as a conservative Mormon, he might not be the most likely candidate to carry a psychedelics bill, but he’s closely studied the existing research and determined that there are “indications of treatment benefits for treatment resistant depression, PTSD, addiction and existential distress” through the use of certain entheogenic substances.
